Please wait while the formulary information is being retrieved.
VASCEPA (ICOSAPENT ETHYL)
- Hypertriglyceridemia
0.5 gram capsule
- 4 capsules (2 gram) by oral route 2 times per day with food swallowing whole. Do not chew, open, dissolve and/or crush.
1 gram capsule
- 2 capsules (2 gram) by oral route 2 times per day with food swallowing whole. Do not chew, open, dissolve and/or crush.
Hypertriglyceridemia
- 2 capsules (2 gram) by oral route 2 times per day with food swallowing whole. Do not chew, open, dissolve and/or crush.
- 4 capsules (2 gram) by oral route 2 times per day with food swallowing whole. Do not chew, open, dissolve and/or crush.
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- Abnormal hepatic function tests
- Disease of liver
VASCEPA (ICOSAPENT ETHYL)
- Hypertriglyceridemia
- None
- None
More Frequent
Severe
Less Severe
- None
- Arthralgias
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- Sore throat
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Icosapent ethyl
No safety and efficacy studies in pediatrics.
- 1 Day – 18 Years
- No safety and efficacy studies in pediatrics.
Icosapent
- Severity Level:
C
- Additional Notes: Insufficient human data; teratogenic in animals at doses 5-7 times the mrhd
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Icosapent
Insufficient human data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Insufficient human data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Hypertriglyceridemia | |
| E78.1 | Pure hyperglyceridemia |
| E78.2 | Mixed hyperlipidemia |
| 0-9 | A-Z |
|---|---|
| E78.1 | Pure hyperglyceridemia |
| E78.2 | Mixed hyperlipidemia |
Formulary Reference Tool